Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
fda
5
×
life sciences
national blog main
national top stories
san diego blog main
5
×
san diego top stories
boston blog main
boston top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
ceo
clinical trials
commissioner
drugs
gene editing
indiana blog main
indiana top stories
ipo
lung cancer
scott gottlieb
shutdown
abbvie
ac immune
acquisition
What
medicine
5
×
fda
bio
loss
patients
roundup
ago
alnylam
approve
awaits
big
biological
biopharma
bosley's
bosley’s
bridge
bucks
cancer
car
cas
celgene
cells
ceo
cleared
clinical
colleagues
company
cosmeceutical
crime
crispr
crossed
decades
decision
departure
diego’s
discovered
drug
editas
eisai
exit
Language
unset
Current search:
fda
×
biotech
×
medicine
×
" san diego blog main "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
6 years ago
Histogen Treatment for Female Hair Loss Cleared for Clinical Testing